First plank solves scenario 1 – that’s 1ac Giordano and DiEuliis’ 21
James Giordano and Diane DiEuliis ’21, *PhD, MPhil, is Professor in the Departments of Neurology and Biochemistry; Chief of the Neuroethics Studies Program; Director of the Cyber-SMART Center’s Program in Biotechnology, Biosecurity and Ethics; Co-director of the Program in Brain Science and Global Law and Policy; and Chair of the Subprogram in Military Medical Ethics at Georgetown University, **is a Senior Research fellow at National Defense University. Her research areas focus on emerging biological technologies, biodefense, and preparedness for biothreats. Specific topic areas under this broad research portfolio include dual-use life sciences research, synthetic biology, the US bioeconomy, disaster recovery, and behavioral, cognitive, and social science as it relates to important aspects of deterrence and preparedness, “Emerging Neuroscience and Technology (NeuroS/T): Current and Near-Term Risks and Threats to US—and Global—Biosecurity”, A STRATEGIC MULTILAYER ASSESSMENT, May 2021, https://nsiteam.com/social/wp-content/uploads/2021/07/SMA-Invited-Perspective_Emerging-NeuroST_Giordano-and-DiEuliis_FINAL.pdf
Additionally, it is important to note that although the US National Academies of Science, Engineering, and Medicine report briefly mentioned recent developments in brain-controlled robotics and brainmachine interface (BMI), neuroS/T, writ large, was not a core aspect of their address. At present, a majority of countries do not yet identify the brain sciences as a principal economic focus. Of the 41 nations that pursued specific political strategies to expand and promote their bioeconomies in 2018, only 10 included neuroS/T research and development objectives.16 So, while there may be little doubt that neuropsychiatric disorders are a significant public health problem, brain research is relatively costly, and the perceived return-on-investment for those countries that do not have substantial neuroepidemiological burdens may not be sufficient to justify pursuing dedicated neuroS/T initiatives. However, while intranational human capital and socio-political agendas of a given nation may not prompt investment and engagement in neuro-bioeconomics, the relative economic—and perhaps cultural and political—hegemony afforded by leveraging global neuroS/T (and overall biological) markets might prove influential to changing perspectives, postures, and participation. To be sure, due to the current lack of emphasis on brain science in national bioeconomic strategies, those countries that initiate policies and programs to invest in neuroS/T may achieve significant financial successes and economic power, and thereby direct future (ethical, technical, and legal) standards of research and use.